Physicians Financial Services Inc. lessened its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 1.3% during the fourth quarter, Holdings Channel.com reports. The fund owned 25,447 shares of the company’s stock after selling 348 shares during the period. Procter & Gamble accounts for about 1.3% of Physicians Financial Services Inc.’s holdings, making the stock its 19th biggest holding. Physicians Financial Services Inc.’s holdings in Procter & Gamble were worth $4,266,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in PG. Concurrent Investment Advisors LLC raised its stake in Procter & Gamble by 4.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after purchasing an additional 4,035 shares during the period. Strategic Advisors LLC boosted its position in Procter & Gamble by 3.4% during the fourth quarter. Strategic Advisors LLC now owns 55,912 shares of the company’s stock valued at $9,374,000 after purchasing an additional 1,818 shares during the last quarter. Copley Financial Group Inc. purchased a new stake in shares of Procter & Gamble during the 3rd quarter worth about $668,000. Fortem Financial Group LLC acquired a new stake in shares of Procter & Gamble during the 4th quarter valued at about $569,000. Finally, Richard C. Young & CO. LTD. grew its stake in shares of Procter & Gamble by 2.1% in the 4th quarter. Richard C. Young & CO. LTD. now owns 123,853 shares of the company’s stock valued at $20,764,000 after buying an additional 2,568 shares in the last quarter. 65.77% of the stock is owned by institutional investors.
Insider Activity
In other news, insider Marc S. Pritchard sold 90,450 shares of the stock in a transaction on Thursday, January 23rd. The stock was sold at an average price of $163.84, for a total transaction of $14,819,328.00. Following the completion of the transaction, the insider now owns 172,814 shares in the company, valued at approximately $28,313,845.76. This represents a 34.36 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the sale, the chief executive officer now directly owns 39,977 shares in the company, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.18% of the company’s stock.
Procter & Gamble Stock Performance
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The business had revenue of $21.88 billion for the quarter, compared to analyst estimates of $21.66 billion. During the same quarter in the prior year, the company earned $1.84 earnings per share. The company’s quarterly revenue was up 2.1% on a year-over-year basis. Research analysts anticipate that The Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, February 18th. Investors of record on Friday, January 24th were given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.41%. The ex-dividend date of this dividend was Friday, January 24th. Procter & Gamble’s payout ratio is 64.17%.
Analyst Ratings Changes
PG has been the subject of several recent analyst reports. Royal Bank of Canada reiterated a “sector perform” rating and set a $164.00 price target on shares of Procter & Gamble in a research note on Thursday, January 23rd. Wells Fargo & Company lifted their target price on Procter & Gamble from $176.00 to $180.00 and gave the stock an “overweight” rating in a research report on Thursday, January 23rd. Barclays increased their price objective on shares of Procter & Gamble from $155.00 to $159.00 and gave the company an “equal weight” rating in a research note on Thursday, January 23rd. DA Davidson reaffirmed a “buy” rating and issued a $209.00 target price on shares of Procter & Gamble in a report on Thursday, January 23rd. Finally, UBS Group dropped their target price on shares of Procter & Gamble from $196.00 to $189.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. Eight equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $180.53.
Read Our Latest Stock Report on Procter & Gamble
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
- Five stocks we like better than Procter & Gamble
- EV Stocks and How to Profit from Them
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- What is a Secondary Public Offering? What Investors Need to Know
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Technology Stocks Explained: Here’s What to Know About Tech
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.